CELLULAR BIOMEDICINE GROUP I's ticker is CBMG and the CUSIP is 15117P102. A total of 41 filers reported holding CELLULAR BIOMEDICINE GROUP I in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $266,000 | -2.2% | 15,375 | 0.0% | 0.00% | – |
| Q4 2018 | $272,000 | -49.8% | 15,375 | -48.5% | 0.00% | – |
| Q3 2018 | $542,000 | +85.6% | 29,866 | +100.0% | 0.00% | – |
| Q2 2018 | $292,000 | +33.9% | 14,933 | -19.2% | 0.00% | – |
| Q1 2017 | $218,000 | -9.9% | 18,476 | 0.0% | 0.00% | – |
| Q4 2016 | $242,000 | -9.7% | 18,476 | 0.0% | 0.00% | – |
| Q3 2016 | $268,000 | +36.0% | 18,476 | +12.2% | 0.00% | – |
| Q2 2016 | $197,000 | -35.8% | 16,469 | 0.0% | 0.00% | -100.0% |
| Q1 2016 | $307,000 | -1.0% | 16,469 | +14.0% | 0.00% | 0.0% |
| Q4 2015 | $310,000 | +26.5% | 14,443 | 0.0% | 0.00% | – |
| Q3 2015 | $245,000 | -54.8% | 14,443 | 0.0% | 0.00% | -100.0% |
| Q2 2015 | $542,000 | – | 14,443 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PLATINUM INVESTMENT MANAGEMENT LTD | 715,351 | $11,617,000 | 0.23% |
| ARK Investment Management | 411,880 | $6,689,000 | 0.17% |
| Nikko Asset Management Americas, Inc. | 532,825 | $8,653,000 | 0.14% |
| HHLR ADVISORS, LTD. | 235,214 | $3,820,000 | 0.05% |
| Vident Investment Advisory, LLC | 17,479 | $284,000 | 0.02% |
| Sumitomo Mitsui Trust Holdings, Inc. | 532,825 | $8,653,000 | 0.01% |
| MEEDER ASSET MANAGEMENT INC | 3,195 | $52,000 | 0.00% |
| Russell Investments Group, Ltd. | 67,474 | $1,094,000 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 312,782 | $5,078,000 | 0.00% |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 18,629 | $303,000 | 0.00% |